Skip to main content
. 2021 Dec 10;22(24):13297. doi: 10.3390/ijms222413297

Figure 8.

Figure 8

Associations of each classified group with clinical outcome. Clinical significance of molecular signatures assembled with (A) cytokines selected by antibody arrays, (B) proteins selected from MS–MS discovery assays in the CAF-200 secretome, (C) proteins associated in the functional enrichment analysis with neutrophil degranulation and (D) proteins related to immune system. Kaplan–Meier curves showing associations of expression levels of proteins with RFS in breast cancer are presented.